loadpatents
name:-0.014487028121948
name:-0.012500047683716
name:-0.0048408508300781
Nagan; Narasimhan Patent Filings

Nagan; Narasimhan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nagan; Narasimhan.The latest application filed is for "methods of detecting mutations associated with ataxia-ocular apraxia 2 (aoa2)".

Company Profile
4.12.12
  • Nagan; Narasimhan - South Grafton MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Mutations associated with cystic fibrosis
Grant 10,865,450 - Rohlfs , et al. December 15, 2
2020-12-15
Methods Of Detecting Mutations Associated With Ataxia-ocular Apraxia 2 (aoa2)
App 20200149107 - Braastad; Corey D. ;   et al.
2020-05-14
Mutations Associated with Cystic Fibrosis
App 20190367985 - Rohlfs; Elizabeth ;   et al.
2019-12-05
Mutations associated with cystic fibrosis
Grant 10,233,499 - Rohlfs , et al.
2019-03-19
Mutations Associated With Cystic Fibrosis
App 20170218452 - Rohlfs; Elizabeth ;   et al.
2017-08-03
Methods Of Detecting Mutations Associated With Ataxia-ocular Apraxia 2 (aoa2)
App 20170166970 - Braastad; Corey D. ;   et al.
2017-06-15
Mutations associated with cystic fibrosis
Grant 9,631,238 - Rohlfs , et al. April 25, 2
2017-04-25
Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
Grant 9,611,512 - Braastad , et al. April 4, 2
2017-04-04
Mutations Associated With Cystic Fibrosis
App 20160138107 - Rothlfs; Elizabeth ;   et al.
2016-05-19
Mutations associated with cystic fibrosis
Grant 9,234,243 - Rohlfs , et al. January 12, 2
2016-01-12
Methods Of Detecting Mutations Associated With Ataxia-ocular Apraxia 2 (aoa2)
App 20140323318 - BRAASTAD; Corey D. ;   et al.
2014-10-30
Mutations Associated With Cystic Fibrosis
App 20140234842 - Rohlfs; Elizabeth ;   et al.
2014-08-21
Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
Grant 8,785,122 - Braastad , et al. July 22, 2
2014-07-22
Mutations associated with cystic fibrosis
Grant 8,728,731 - Rohlfs , et al. May 20, 2
2014-05-20
Methods Of Detecting Mutations Associated With Ataxia-ocular Apraxia 2 (aoa2)
App 20120237934 - Braastad; Corey D. ;   et al.
2012-09-20
Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
Grant 8,192,933 - Braastad , et al. June 5, 2
2012-06-05
Mutations Associated With Cystic Fibrosis
App 20110230365 - Rohlfs; Elizabeth ;   et al.
2011-09-22
Identification of a novel gene underlying familial spastic paraplegia
Grant 7,811,762 - Zuchner , et al. October 12, 2
2010-10-12
Methods of Detecting Mutations Associated With Ataxia-Ocular Apraxia 2 (AOA2)
App 20100167305 - Braastad; Corey D. ;   et al.
2010-07-01
Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
Grant 7,704,691 - Braastad , et al. April 27, 2
2010-04-27
Identification of a novel gene underlying familial spastic paraplegia
App 20070248974 - Zuchner; Stephan ;   et al.
2007-10-25
Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2)
App 20070190555 - Braastad; Corey D. ;   et al.
2007-08-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed